Can bupropion (Wellbutrin) and propranolol be used to treat ADHD with comorbid anxiety?

Bupropion and Propranolol for ADHD with Comorbid Anxiety

Bupropion can be used as an alternative treatment for ADHD when stimulants are contraindicated or not tolerated, but stimulant medications remain first-line even in the presence of comorbid anxiety, and propranolol has no established role in treating either ADHD or anxiety disorders in this context. 1, 2

First-Line Treatment: Stimulants Despite Anxiety Comorbidity

• Stimulant medications (methylphenidate or amphetamines) are the first-line pharmacotherapy for ADHD symptoms even when comorbid anxiety is present. 3, 1
• Double-blind trials demonstrate that stimulants effectively treat ADHD in patients with tic disorders and anxiety, with the majority of patients not experiencing anxiety worsening. 3, 1
• Stimulants frequently result in improvement not only in ADHD symptoms but also in alleviating symptoms of the comorbid anxiety disorder. 2
• Despite common concerns about anxiety exacerbation, stimulant medications demonstrate good tolerability and good response in addressing symptoms in this comorbid population. 1

Bupropion as an Alternative Agent

When stimulants cannot be used, bupropion represents a reasonable second-line option for ADHD, though its effects on comorbid anxiety are mixed and require careful monitoring. 4, 5

Efficacy for ADHD

• Bupropion produces a 42% reduction in ADHD symptoms compared to 24% with placebo, with 76% of patients achieving ≥30% symptom reduction versus 37% with placebo. 4
• In head-to-head comparison, bupropion demonstrated equivalent efficacy to methylphenidate for ADHD symptoms in children and adolescents (ages 7-17). 6
• A Cochrane review found low-quality evidence that bupropion decreased ADHD severity (standardized mean difference -0.50) and increased clinical improvement rates (RR 1.50). 7

Effects on Anxiety: Critical Caveat

Bupropion has paradoxical effects on anxiety that require careful consideration—it may reduce anxiety in some patients but provoke or worsen it in others, particularly at higher doses. 5

• Clinical trials suggest bupropion may reduce anxiety symptoms in depressed patients, showing comparable efficacy to SSRIs and SNRIs in mild to moderate anxiety. 5
• In a pilot trial for generalized anxiety disorder, bupropion XL (150-300 mg/day) demonstrated comparable anxiolytic efficacy to escitalopram. 8
• However, bupropion's stimulating properties (via norepinephrine and dopamine reuptake inhibition) can provoke anxiety, particularly at higher doses. 5
• The FDA label lists anxiety as occurring in 5-7% of patients on bupropion versus 3-5% on placebo, and "feeling jittery" occurs in 3% versus 2% on placebo. 9

Dosing and Administration

• Start bupropion XL at 150 mg once daily in the morning; after 4-7 days, may increase to target dose of 300 mg once daily. 9
• Doses above 300 mg daily were not assessed in controlled trials for most indications. 9
• Swallow tablets whole—do not crush, divide, or chew. 9
• May be taken with or without food. 9

Monitoring Requirements

• Monitor closely for worsening anxiety, agitation, insomnia, and emergence of suicidal thoughts, especially in patients under age 25. 9, 5
• If anxiety worsens on bupropion, discontinue and consider alternative agents. 5
• Monitor blood pressure, as hypertension occurs in 2% of patients (0% with placebo). 9

Propranolol: No Established Role

Propranolol has no evidence-based indication for treating ADHD or generalized anxiety disorder in this population. While beta-blockers like propranolol are sometimes used for performance anxiety or physical symptoms of anxiety (tremor, tachycardia), they do not address the core symptoms of either ADHD or anxiety disorders and are not mentioned in any ADHD or anxiety treatment guidelines for this indication.

Optimal Treatment Algorithm for ADHD with Comorbid Anxiety

Step 1: Initiate Stimulant Medication

• Start with a stimulant (methylphenidate or amphetamine) as first-line treatment, regardless of anxiety comorbidity. 3, 1, 2
• Monitor for both ADHD symptom improvement and anxiety response over 2-4 weeks. 1

Step 2: If Anxiety Persists Despite ADHD Improvement

• Add cognitive-behavioral therapy (CBT) specifically targeting anxiety—this is superior to medication alone. 1, 2
• If anxiety remains moderate to severe, add an SSRI (selective serotonin reuptake inhibitor) to the stimulant with careful monitoring. 2

Step 3: If Stimulants Are Contraindicated or Not Tolerated

• Consider atomoxetine as the preferred alternative—it demonstrates impressive efficacy for both ADHD and anxiety disorder symptoms simultaneously. 3, 2
• Atomoxetine dosing: up to 1.8 mg/kg or maximum 120 mg per day, with therapeutic effects emerging after 6-12 weeks. 3
• Atomoxetine provides continuous symptom control without worsening tics or anxiety and is a non-controlled substance. 3

Step 4: If Atomoxetine Fails or Is Not Tolerated

• Consider bupropion 150-300 mg daily as a third-line option. 4, 7
• Start at 150 mg daily and monitor closely for anxiety worsening before increasing to 300 mg. 9, 5
• If anxiety worsens, discontinue bupropion and return to atomoxetine or consider alpha-2 agonists (guanfacine or clonidine). 3

Critical Pitfalls to Avoid

• Do not avoid stimulants solely because anxiety is present—this is the most common error, as stimulants often improve both conditions. 1, 2
• Do not use bupropion as first-line when stimulants or atomoxetine are viable options—the evidence base is weaker and anxiety effects are unpredictable. 7, 10
• Do not prescribe propranolol for ADHD or generalized anxiety disorder—it lacks efficacy for these conditions and may cause fatigue that worsens ADHD symptoms.
• Do not increase bupropion above 300 mg daily in pursuit of better ADHD control if anxiety symptoms emerge—higher doses increase anxiogenic risk. 5
• Do not neglect psychosocial interventions, particularly CBT for anxiety, which is essential for optimal outcomes. 1, 2